The normal tissue samples of 22 patients (41%) contained TP53 mutations, in most cases in very low frequencies around 1-2%, and only in few cases the frequency increased noteworthy going through the pre-cancer, tumor, and metastasis tissue. Here, TP53 is linked to neoplasm.